tbResList Print — VitA,RetA Vitamin A, Retinoic Acid

Filters: qv=290, qv2=%, rfv=%

Product

VitA,RetA Vitamin A, Retinoic Acid
Description: <b>Retinoic acid</b> is a naturally occurring derivative of vitamin A (retinol).<br>
<br>
Retinoic acid is produced in the body from dietary vitamin A. Vitamin A can be ingested in two primary forms:<br>
• Preformed vitamin A (retinol and its esters) found in animal products like liver, dairy, and fish.<br>
• Provitamin A carotenoids (such as beta-carotene) found in colorful fruits and vegetables.
Once ingested, these compounds are converted into retinol, which can then be oxidized to retinal and further oxidized to retinoic acid.<br>
<br>
All-trans retinoic acid (ATRA) is a key component in the treatment of acute promyelocytic leukemia (APL). In APL, ATRA induces the differentiation of malignant promyelocytes into mature granulocytes, leading to clinical remission.<br>
<br>
-Retinoic acid can have antioxidant properties<br>
-High levels of retinoic acid have been associated with increased ROS production and oxidative stress<br>
-The potential prooxidant action may contribute to its anti-cancer effects by inducing oxidative damage in cancer cells, thereby enhancing apoptosis.<br>

Pathway results for Effect on Cancer / Diseased Cells

NA, unassigned(tgid=0)

KAI1/CD82↑, 1,  

Cell Death(tgid=5)

Apoptosis↑, 1,  

Transcription & Epigenetics(tgid=7)

other↝, 1,  

DNA Damage & Repair(tgid=10)

DNAdam↑, 1,   P53↑, 1,  

Cell Cycle & Senescence(tgid=11)

TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12)

Diff↑, 1,  

Migration(tgid=13)

CD11b↑, 1,   MMP9↓, 1,   TumCP↓, 1,  

Immune & Inflammatory Signaling(tgid=16)

IL1β↓, 1,  

Synaptic & Neurotransmission(tgid=18)

p‑tau↓, 1,  

Drug Metabolism & Resistance(tgid=21)

ChemoSen↓, 1,   Dose↝, 1,   eff↓, 1,   eff↑, 3,   RadioS↓, 1,  

Functional Outcomes(tgid=23)

memory↑, 1,   Risk∅, 1,  
Total Targets: 19

Pathway results for Effect on Normal Cells

Redox & Oxidative Stress(tgid=1)

ROS↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12)

neuroG↑, 1,  

Immune & Inflammatory Signaling(tgid=16)

Inflam↓, 1,  

Synaptic & Neurotransmission(tgid=18)

ADAM10↑, 3,  

Protein Aggregation(tgid=19)

Aβ↓, 1,   BACE↓, 1,  

Functional Outcomes(tgid=23)

cognitive↑, 1,   neuroP↑, 1,   radioP↑, 1,  
Total Targets: 9

Research papers

Year Title Authors PMID Link Flag
2022Using Supplements During Chemo: Yes or No?Karen Sabbath, MS, RD, CSOhttps://www.leevercancercenter.org/blog/using-supplements-during-chemo-yes-or-no/0
2023Combined dandelion extract and all-trans retinoic acid induces cytotoxicity in human breast cancer cellsHamed Rezaiehttps://www.nature.com/articles/s41598-023-42177-z0
2014Dietary supplement use and colorectal cancer risk: a systematic review and meta-analyses of prospective cohort studiesRenate C Heine-Bröring25335850https://pubmed.ncbi.nlm.nih.gov/25335850/0
2016Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivoFarzaneh AtashrazmPMC5216779https://pmc.ncbi.nlm.nih.gov/articles/PMC5216779/0
2020Target Enzymes Considered for the Treatment of Alzheimer's Disease and Parkinson's DiseaseNamdoo KimPMC7669341https://pmc.ncbi.nlm.nih.gov/articles/PMC7669341/0
2025Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiologyVipul Sharmahttps://www.sciencedirect.com/science/article/pii/S26670321250000710
2023Vitamins and Radioprotective Effect: A ReviewInés LledóPMC10045031https://pmc.ncbi.nlm.nih.gov/articles/PMC10045031/0